Navigation Links
S.E.D. Labs to be Acquired by Quest Diagnostics
Date:1/3/2012

ALBUQUERQUE, N.M. and MADISON, N.J., Jan. 3, 2012 /PRNewswire/ -- S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated (NYSE: DGX), the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.  According to the agreement, Quest Diagnostics will acquire the assets of S.E.D. Medical Laboratories and manage in-patient labs for the four Lovelace hospitals, as well as serve Lovelace Health Plan members.  Financial terms of the transaction, which is expected to be completed this month, were not disclosed.

Based in Albuquerque, New Mexico, S.E.D. Medical Laboratories is a nationally recognized full-service medical and federally certified drugs-of-abuse testing laboratory with a staff of 450. S.E.D. operates from a modern 50,000 square-foot facility with state-of-the-art equipment and cutting-edge technology. The acquisition agreement includes the transfer of the main offices and lab on Office Boulevard near I-25 and Jefferson, nine Patient Service Centers in Albuquerque and Rio Rancho and six additional locations across New Mexico. 

"This agreement will provide S.E.D. and its medical and scientific staff with more access to innovation, new technology and capital resources," said Ron Stern, president and CEO of the Lovelace Health System.  "Quest Diagnostics is a leading provider of diagnostic testing in the world. Its access to new technology will also help to further improve diagnosis, and Lovelace patients and health plan members will benefit from its experience and scale."

"This represents a commitment by Quest Diagnostics to the New Mexico healthcare community, and will significantly increase our presence in the state," said Catherine T. Doherty, Senior Vice President, Physician Services Business for Quest Diagnostics. "We look forward to joining together with S.E.D. Laboratories to serve Lovelace Health System and its patients and health plan members. In addition, this transaction will drive growth and is consistent with our stated approach to capital deployment."

Lovelace has invested more than $8 million in S.E.D. since it acquired the lab from St. Joseph Healthcare System in late 2002 and combined it with the Lovelace lab network in early 2003.  Among the large capital projects was the lab automation system put in place last fall.

About Lovelace
Lovelace Health System comprises a network of acute-care hospitals, a rehabilitation hospital, the Lovelace Health Plan offering access to a wide range of health care providers and specialists across New Mexico, S.E.D. Medical Laboratories, and retail pharmacy locations in Albuquerque, Rio Rancho and Santa Fe.

About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com or follow us at Facebook.com/QuestDiagnostics and Twitter.com/QuestDX.Contacts:

For Lovelace Health System:

 For Quest Diagnostics: 

Laurie Volkin

 Kathleen Valentine (Investors)  

(505) 727-5503

973-520-2900  

laurie.volkin@lovelace.com

kathleen.m.valentine@questdiagnostics.com 

 

Gary Samuels (Media) 

 

973-520-2800  

 

gary.d.samuels@questdiagnostics.com


'/>"/>
SOURCE Quest Diagnostics Incorporated; Lovelace Health System
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Amnis Acquired by EMD Millipore - Expands Growth Potential
2. A*Star scientists discover how to combat hospital-acquired infections and life-threatening toxins
3. ReportsnReports - Needle-Free Drug Delivery Market & Hospital-Acquired Infections (HAI) Diagnostics Market Reports
4. China Agri-Business Acquired Management and Operation Rights of Shaanxi Qinfeng Agrochemical Inc. in Xian, China
5. Cord Blood America Announces BioCells, Inc., Which it Acquired in 2010, is Opening Office in Miami, Florida and 5 New Offices in Argentina Soon
6. Omnicare Clinical Research Acquired by Nautic Partners, LLC
7. Newly Published Study Shows Dramatic Reduction in Hospital Acquired Infections
8. International Technidyne Corporation Acquired by Warburg Pincus
9. Abt Bio-Pharma Solutions, Inc. Acquired by United BioSource Corporation
10. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
11. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 17, 2017  On January 10 at the Medtech ... Morgan Healthcare Conference in San Francisco ... , spoke to pharmaceutical leaders and public and private ... break down and destroy biofilms.  Biofilms ... antibiotics and the body,s immune system from eradicating chronic ...
(Date:1/16/2017)... , Jan. 16, 2017   Valentin A. ... Tracey, MD , president and CEO of The ... completed an analysis of how the nervous system regulates ... and develop bioelectronic medicine devices to treat ... Nature Neuroscience . The paper examines ...
(Date:1/16/2017)...  Eurofins Genomics today announced the expansion of its ... receive their primers in a shorter turnaround time, without ... with other providers. Express oligos are available for anyone ... no additional fee. Researchers use the oligos ... sequencing, genotyping, site-directed mutagenesis, and cloning. Often, they are ...
(Date:1/14/2017)... , Jan. 13, 2017  The Alliance for Safe ... response to FDA final guidance on biologic ... continued leadership in emphasizing the importance of distinct naming ... aware of the benefits biosimilars will bring to patients, ... Yet the portion of the Guidance dealing with ...
Breaking Biology Technology:
(Date:1/6/2017)... 5, 2017  Delta ID Inc., a leader in ... for automotive at CES® 2017. Delta ID has collaborated ... demonstrate the use of iris scanning as a secure, ... driver in a car, and as a way to ... Delta ID and Gentex will demonstrate (booth ...
(Date:12/22/2016)... 20, 2016  As part of its longstanding mission to ... genetics company, recently released its latest children,s book, titled ... focuses on the topics of inheritance and variation of traits ... taught in elementary school classrooms in the US. ... illustrator Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/19/2016)... , España y TORONTO , 19 de ... con Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, ... clínicos en varios tipos de tumor en 2017, con múltiples sitios ... ... su clase con objetivo en el factor inhibidor de leucemia (LIF), ...
Breaking Biology News(10 mins):